APA (7th ed.) Citation

NCH, d. V., S, J., MCM, S., S, P., S, V. d. B., N, D., . . . H, D. R. (2023). Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs. Frontiers in pharmacology, 14, 1266288. https://doi.org/10.3389/fphar.2023.1266288

Chicago Style (17th ed.) Citation

NCH, do Valle, Janssen S, Stroet MCM, Pollenus S, Van den Block S, Devoogdt N, Debacker JM, Hernot S, and De Rooster H. "Safety Assessment of Fluorescently Labeled Anti-EGFR Nanobodies in Healthy Dogs." Frontiers in Pharmacology 14 (2023): 1266288. https://doi.org/10.3389/fphar.2023.1266288.

MLA (9th ed.) Citation

NCH, do Valle, et al. "Safety Assessment of Fluorescently Labeled Anti-EGFR Nanobodies in Healthy Dogs." Frontiers in Pharmacology, vol. 14, 2023, p. 1266288, https://doi.org/10.3389/fphar.2023.1266288.